Saturday, November 22, 2008 - 11:34AM EST

Clinical Trials

1. An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis.

Author
Pham T; Landewe R; van der Linden S; Dougados M; Sieper J; Braun J; Davis J; Rudwaleit M; Collantes E; Burgos-Vargas R; Edmonds J; Olivieri I; van der Horst-Bruinsma I; Mielants H; Stone M; Emery P; van der Heijde D; Pham T; Landewe R; van der Linden S; Dougados M; Sieper J; Braun J; Davis J; Rudwaleit M; Collantes E; Burgos-Vargas R; Edmonds J; Olivieri I; van der Horst-Bruinsma I; Mielants H; Stone M; Emery P; van der Heijde D;
Institution
Department of Rheumatology, Aix-Marseille II University, Conception Hospital, 147 bd Baille, 13005 Marseille, France. thao.pham@ap-hm.fr
Journal
Ann Rheum Dis. 2006 Dec;65(12):1620-5. Epub 2006 Feb 7.
Abstract URL
Click here to view abstract

2. Adalimumab reduces spinal symptoms in active ankylosing spondylitis: clinical and magnetic resonance imaging results of a fifty-two-week open-label trial.

Author
Haibel H; Rudwaleit M; Brandt HC; Grozdanovic Z; Listing J; Kupper H; Braun J; Sieper J;
Institution
Benjamin Franklin Hospital, Berlin, Germany.
Journal
Arthritis Rheum. 2006 Feb;54(2):678-81.

3. Response to one infusion predicts subsequent improvement as well as the rate of relapse of ankylosing spondylitis infused with three pulses of infliximab.

Author
Huang F; Zhu J; Zhang L; Zhang J; Zhang F; Yu D; Huang F; Zhu J; Zhang L; Zhang J; Zhang F; Yu D;
Institution
Department of Rheumatology, Chinese PLA General Hospital, Beijing, 100853, China, fhuang1964@yahoo.com.
Journal
Clin Rheumatol. 2007 Jun;26(6):920-6. Epub 2006 Oct 5.
Abstract URL
Click here to view abstract

4. MRI of the sacroiliac joints in patients with moderate to severe ankylosing spondylitis.

Author
Bredella MA; Steinbach LS; Morgan S; Ward M; Davis JC; Bredella MA; Steinbach LS; Morgan S; Ward M; Davis JC;
Institution
Department of Radiology, University of California, San Francisco, San Francisco, CA, USA. mbredella@partners.org
Journal
AJR Am J Roentgenol. 2006 Dec;187(6):1420-6.
Abstract URL
Click here to view abstract

5. Supplementation of omega-3 fatty acids in patients with ankylosing spondylitis.

Author
Sundstrom B; Stalnacke K; Hagfors L; Johansson G;
Institution
Department of Medical Rehabilitation, Gallivare Hospital, Sweden. bjorn.sundstrom@nll.se
Journal
Scand J Rheumatol. 2006 Sep-Oct;35(5):359-62.
Abstract URL
Click here to view abstract

6. Switching from infliximab to once-weekly administration of 50 mg etanercept in resistant or intolerant patients with ankylosing spondylitis: results of a fifty-four-week study.

Author
Cantini F; Niccoli L; Benucci M; Chindamo D; Nannini C; Olivieri I; Padula A; Salvarani C; Cantini F; Niccoli L; Benucci M; Chindamo D; Nannini C; Olivieri I; Padula A; Salvarani C;
Institution
Unita Reumatologica, Hospital of Prato, Prato, Italy. fcantini@usl4.toscana.it
Journal
Arthritis Rheum. 2006 Oct 15;55(5):812-6.

7. Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis.

Author
van der Heijde D; Da Silva JC; Dougados M; Geher P; van der Horst-Bruinsma I; Juanola X; Olivieri I; Raeman F; Settas L; Sieper J; Szechinski J; Walker D; Boussuge MP; Wajdula JS; Paolozzi L; Fatenejad S; van der Heijde D; Da Silva JC; Dougados M; Geher P; van der Horst-Bruinsma I; Juanola X; Olivieri I; Raeman F; Settas L; Sieper J; Szechinski J; Walker D; Boussuge MP; Wajdula JS; Paolozzi L; Fatenejad S;
Institution
University Hospital Maastricht, Maastricht, The Netherlands.
Journal
Ann Rheum Dis. 2006 Dec;65(12):1572-7. Epub 2006 Sep 12.
Abstract URL
Click here to view abstract

8. Celecoxib is efficacious and well tolerated in treating signs and symptoms of ankylosing spondylitis.

Author
Barkhuizen A; Steinfeld S; Robbins J; West C; Coombs J; Zwillich S;
Institution
Department of Medicine, Oregon Health and Science University and Portland Veterans Affairs Medical Center, Portland, Oregon 97239, USA. barkhuiz@ohsu.edu
Journal
J Rheumatol. 2006 Sep;33(9):1805-12.
Abstract URL
Click here to view abstract

9. Development and validation of the Edmonton Ankylosing Spondylitis Metrology Index.

Author
Maksymowych WP; Mallon C; Richardson R; Conner-Spady B; Jauregui E; Chung C; Zappala L; Pile K; Russell AS;
Institution
University of Alberta, Edmonton, Alberta, Canada. walter.maksymowych@ualberta.ca
Journal
Arthritis Rheum. 2006 Aug 15;55(4):575-82.
Abstract URL
Click here to view abstract

10. Infliximab improves productivity and reduces workday loss in patients with ankylosing spondylitis: results from a randomized, placebo-controlled trial.

Author
van der Heijde D; Han C; DeVlam K; Burmester G; van den Bosch F; Williamson P; Bala M; Han J; Braun J;
Institution
University Hospital Maastricht, Maastricht, The Netherlands. dhe@sint.azm.nl
Journal
Arthritis Rheum. 2006 Aug 15;55(4):569-74.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4